Alto Neuroscience, Inc. (ANRO)

USD 2.08

(-2.35%)

Gross Profit Summary of Alto Neuroscience, Inc.

  • Alto Neuroscience, Inc.'s latest annual gross profit in 2023 was -373 Thousand USD , down -9.06% from previous year.
  • Alto Neuroscience, Inc.'s latest quarterly gross profit in 2024 Q1 was -97 Thousand USD , down -134.64% from previous quarter.
  • Alto Neuroscience, Inc. reported a annual gross profit of -342 Thousand USD in annual gross profit 2022, down -626.15% from previous year.
  • Alto Neuroscience, Inc. reported a annual gross profit of 65 Thousand USD in annual gross profit 2021, down 0.0% from previous year.
  • Alto Neuroscience, Inc. reported a quarterly gross profit of -100 Thousand USD for 2024 Q2, down -3.09% from previous quarter.
  • Alto Neuroscience, Inc. reported a quarterly gross profit of -100 Thousand USD for 2023 Q2, down -16.28% from previous quarter.

Annual Gross Profit Chart of Alto Neuroscience, Inc. (2023 - 2021)

Historical Annual Gross Profit of Alto Neuroscience, Inc. (2023 - 2021)

Year Gross Profit Gross Profit Growth
2023 -373 Thousand USD -9.06%
2022 -342 Thousand USD -626.15%
2021 65 Thousand USD 0.0%

Peer Gross Profit Comparison of Alto Neuroscience, Inc.

Name Gross Profit Gross Profit Difference
ADC Therapeutics SA 67.02 Million USD 100.556%
Annovis Bio, Inc. - USD Infinity%
Biohaven Pharmaceutical Holding Company Ltd. -3.36 Million USD 88.928%
Ginkgo Bioworks Holdings, Inc. 197.45 Million USD 100.189%
Nuvation Bio Inc. -222 Thousand USD -68.018%
Nuvation Bio Inc. -222 Thousand USD -68.018%
Arcus Biosciences, Inc. -223 Million USD 99.833%
Zymeworks Inc. -66.97 Million USD 99.443%